Weight: Being overweight or obese is associated with higher LDL cholesterol
Wachstums- oder tumorbezogene Therapien: aufgrund der angiogenen Eigenschaften ist bei onkologischen Patienten besondere Zurckhaltung geboten
Orforglipron es un agonista GLP-1 oral de molcula pequea en desarrollo que ha demostrado reducciones de peso del 9,6% con la dosis de 36 mg en pacientes con obesidad y diabetes tipo 2
Dedeaux AM, Flesner BK, Reinhart JM, Langohr IM, Husnik R, Geraci SN, et al
The 2024 NICE NG239 guideline on vitamin B12 deficiency in over-16s lists the main groups who need injections: Autoimmune gastritis (pernicious anaemia)
While it has been FDA-approved for medical use in reducing visceral fat in HIV patients, bodybuilders often use it off-label, where long-term safety data is more limited